Skip to content

Speech therapy in patients with tuberculosis

Speech therapy intervention in patients with tuberculosis in the upper airways and digestive tract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9ryj5d
Enrollment
Unknown
Registered
2019-08-07
Start date
2010-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other forms of airway tuberculosis, with bacteriological and histological confirmation / Dysphonia

Interventions

A convenience sample was used, composed of patients with VADS tuberculosis and who were followed up at the Otorhinolaryngology outpatient clinic of INI / FIOCRUZ. The following phonoaudiological and o
Other
R49.0

Sponsors

Instituto Nacional de Infectologia
Lead Sponsor
Instituto Nacional de Infectologia
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have confirmation of diagnosis of tuberculosis in the upper airways and digestive tract by one or more of the following methods: histopathology, direct examination, culture or PCR; are in attendance at the otorhinolaryngology clinic of INI / FIOCRUZ; consent to participate in the study by signing the consent form.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years; have speech-language pathology at another institution; present chronic diseases that interfere with the otorhinolaryngological evaluation and / or speech-language therapy, such as head and neck neoplasias, stroke, Central Nervous System tumors, among others; patients with mental problems.

Design outcomes

Primary

MeasureTime frame
We hope to be able to evaluate the effectiveness of the implementation of speech-language pathology strategies in the care of patients with infectious diseases of mucosal involvement, such as tuberculosis.

Secondary

MeasureTime frame
We hope that at the end of the drug treatment the patient presents the minimum of functional sequelae, allowing a social reinclusion in the shortest possible time and in the most appropriate way possible.

Countries

Brazil

Contacts

Public ContactClaudia Maria Rosalino

Instituto Nacional de Infectologia

claudia.valete@ini.fiocruz.br+55-21-38659670

Outcome results

None listed

Source: REBEC (via WHO ICTRP)